PFE - יחס חוב להיוון בספרים Pfizer Corporation

Pfizer Inc. is a recognized leader in medicine whose authority is built upon the creation of life-saving vaccines. The debt-to-capitalization ratio on the balance sheet visualizes the asset's financial stability, where 0.73 is the current value of the indicator. Despite the stabilization of its image following the pandemic, this behemoth is directing massive cash flows toward the acquisition of biotech startups to strengthen its market dominance.

Investors view Pfizer Inc. (PFE) as a stable asset whose resilience is determined by the ratio of total liabilities to equity. By analyzing the level of total debt relative to the company's balance sheet equity, one can assess the behemoth's ability to finance the acquisition of biotech startups without bankruptcy risk, confirming the company's status as a defensive asset with a high degree of financial autonomy.